U.S. markets close in 4 hours 20 minutes

Top Ranked Momentum Stocks to Buy for April 27th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 27th:

Avenue Therapeutics, Inc. (ATXI): This specialty pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.6% over the last 60 days.    

Avenue Therapeutics, Inc. Price and Consensus

Avenue Therapeutics, Inc. Price and Consensus

Avenue Therapeutics, Inc. price-consensus-chart | Avenue Therapeutics, Inc. Quote

Avenue Therapeutics’ shares gained 15.4% over the last one month above the S&P 500’s increase of 7.9%. The company possesses a Momentum Score of A.

Avenue Therapeutics, Inc. Price

Avenue Therapeutics, Inc. Price

Avenue Therapeutics, Inc. price | Avenue Therapeutics, Inc. Quote

Can-Fite BioPharma Ltd. (CANF): This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.9% over the last 60 days.

Can-Fite Biopharma Ltd Price and Consensus

Can-Fite Biopharma Ltd Price and Consensus

Can-Fite Biopharma Ltd price-consensus-chart | Can-Fite Biopharma Ltd Quote

Can-Fite BioPharma’s shares gained 25.9% over the last one month. The company possesses a Momentum Score of A.

Can-Fite Biopharma Ltd Price

Can-Fite Biopharma Ltd Price

Can-Fite Biopharma Ltd price | Can-Fite Biopharma Ltd Quote

Gold Fields Limited (GFI): This gold producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45% over the last 60 days.

Gold Fields Limited Price and Consensus

Gold Fields Limited Price and Consensus

Gold Fields Limited price-consensus-chart | Gold Fields Limited Quote

Gold Fields’ shares gained 41.5% over the last one month. The company possesses a Momentum Score of B.

Gold Fields Limited Price

Gold Fields Limited Price

Gold Fields Limited price | Gold Fields Limited Quote

Manning & Napier, Inc. (MN): This investment manager has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.2% over the last 60 days.

Manning & Napier, Inc. Price and Consensus

Manning & Napier, Inc. Price and Consensus

Manning & Napier, Inc. price-consensus-chart | Manning & Napier, Inc. Quote

Manning & Napier’s shares gained 159.8% over the last one month. The company possesses a Momentum Score of B.

Manning & Napier, Inc. Price

Manning & Napier, Inc. Price

Manning & Napier, Inc. price | Manning & Napier, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Manning & Napier, Inc. (MN) : Free Stock Analysis Report
 
Gold Fields Limited (GFI) : Free Stock Analysis Report
 
Can-Fite Biopharma Ltd (CANF) : Free Stock Analysis Report
 
Avenue Therapeutics, Inc. (ATXI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.